Moreover, LPS increased plasma 12,13-EpOME at +12H, but not +2H, pointing toward a time-dependent activation of the CYP and sEH pathways that may contribute to the progression of inflammation and vascular permeability in the later stages of endotoxemia. The gene discussed is EPHX2; the disease is serum lipopolysaccharide activity.